We found methylation scores for CD56+ dim NK cells, and activated and effector memory CD8+ T cells, to be significantly prognostic across multiple cancer cohorts including melanoma, with low methylation levels inferring good prognosis in most cancer types (Fig. 6C). Here, NCAM1 is linked to melanoma.